Nausea/Vomiting
Atmo capsule may offer ‘potential replacement’ for nixed SmartPill in motility disorders
PHILADELPHIA — An ingestible gas-sensing capsule from Atmo Biosciences showed “substantial agreement” with the discontinued Medtronic wireless motility device for measuring regional transit times in gastrointestinal motility disorders.
Nutrient intake lower on days with nausea or vomiting in episodic migraine
SAN DIEGO —Individuals with episodic migraine had lower nutrient intake on days with nausea or vomiting compared with days without nausea, according to a poster from the American Headache Society Annual Scientific Meeting.
FDA approves Duvyzat for treatment of Duchenne muscular dystrophy
The FDA has approved Duvyzat for the treatment of Duchenne muscular dystrophy among patients aged 6 years and older, according to a press release.
Q&A: In utero exposure to Bendectin linked to increased risk for CRC in adult offspring
Prenatal exposure in the 1960s and ’70s to dicyclomine, a component of the anti-nausea drug Bendectin, increased the risk for colorectal cancer in adult offspring, according to data reported in JNCI Cancer Spectrum.
Q&A: Spreading awareness during gastroparesis awareness month
Gastroparesis, a chronic and long-term gastrointestinal disorder, is estimated to burden 5 million individuals in the United States with crippling symptoms of delayed gastric emptying.
Small study finds gabapentin effectively treats hyperemesis gravidarum
Gabapentin may be more effective than standard therapy for hyperemesis gravidarum, according to results of a small trial presented at this year’s virtual American College of Obstetrics and Gynecology Annual Clinical and Scientific Meeting.